💊Opdivo Alone or Combined with Yervoy Shows Encouraging Response and Survival Rates in Recurrent Small Cell Lung Cancer Patients with High Tumor Mutation Burden, in Exploratory Analysis from Phase 1/2 Study CheckMate -032 Tuesday October 17th, 2017By Tokio X'press Soverign
💊U.S. Food and Drug Administration (FDA) Accepts Bristol-Myers Squibb’s Application for Opdivo (nivolumab) in Patients with Resected High-Risk Advanced Melanoma and Grants Priority Review Tuesday October 17th, 2017By Tokio X'press Soverign
🏭Swiss Technology On The Rise In China China’s first Kompogas® plant to be built in world’s largest city Tuesday October 17th, 2017By Tokio X'press power generation, JPN hitachi zosen
⛴Mitsui Engineering & Shipbuilding, Niigata Shipbuilding, World’s Largest Towing Capability Tag Third Ship Delivery 20171017 Tuesday October 17th, 2017By Tokio X'press JPN, shipping mes
⛴Mitsui engineering & shipbuilding, high pressure EGR system compatible with NOx tertiary regulation adopted for large marine diesel engine coal carrier Tuesday October 17th, 2017By Tokio X'press JPN, shipping Mitsui engineering
